C o n TA C T
The ArCH 2 (CO)-fragment is present in a number of natural and bioactive molecules such as benzyl ketones and arylacetic acid esters or amides, and therefore represents an important target in organic synthesis. The ketene-surrogate coupling reaction that was developed by Professor Joseph Ready and Wenhan Zhang at the University of Texas Southwestern Medical Center (Dallas, USA) is a very useful method for the synthesis of these structural motifs. Professor Ready said: "The original driving force for developing the ketene-surrogate coupling reaction emerged from an interest in aryl benzyl ketones." This substructure appears in several biologically active xanthone-type molecules, such as simaomi cin α and kigamicin. A convergent approach to aryl benzyl ketones would involve two aryl fragments and a two-carbon conjunctive reagent. Professor Ready said: "For the two-carbon fragment, we selected ketene with the idea that coupling to an aryl group would yield an aryl ketene. If the aryl ketene could be trapped with an aryl carbanion, it would form the second carbon -carbon bond while keeping the carbon in the ketone oxidation state." He continued: "We found that tertbutoxyacetylene could couple with an aryl iodide to generate an aryl-substituted ynol ether, which underwent a [1,5]hydride shift to yield the aryl ketene." However, the direct Grignard addition to aryl ketenes proved challenging, generating a large amount of polymerized material. Accordingly, several alternative stepwise strategies were developed by the Dallas-based researchers to produce the desired ketones, including Fries rearrangement, the addition of Grignard to morpholine amides, and the Liebeskind coupling reaction.
According to Professor Ready, in addition to providing aryl benzyl ketones, this ketene-surrogate coupling shortens the synthesis of arylacetic acid derivatives. Specifically, various aryl iodides couple with tert-butoxyacetylene and yield the aryl ketenes. "In the course of evaluating the scope of the coupling reaction, the aryl ketenes were trapped with morpholine," explained Professor Ready. "Thus, electron-rich or electron-deficient aryls, six-or five-membered heteroaryls, and substituted aryls all gave the morpholine amides in SYNFORM, 2015/01
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The Ketene-Surrogate Coupling: Catalytic Conversion of Aryl Iodides into Aryl Ketenes through Ynol Ethers Angew. Chem. Int. Ed. 2014, 53, 8980-8984 used to trap the ketene intermediates." Heteroatom-based nucleophiles, such as oxygen, nitrogen, and sulfur, can trap the aryl ketene intermediates yielding acids, esters, thioesters, and amides. Alternatively, enol ethers undergo [2+2] cycloadditions with the intermediate ketenes while Wittig reagents form allenes. The variability of both aryl iodides and nucleophiles provides the potential to build diverse libraries for drug discovery. Professor Ready explained: "2-Vinyl iodobenzenes can form ortho-vinyl aryl ketenes under our protocol, and these intermediates undergo a 6π-electrocyclic ring closure to produce naphthols, quinolinols, and isoquinolinols. Now, we are focusing on the annulation of those substrates containing heteroatoms, which will allow us to rapidly install the cores of some drug-like molecules. The cyclization of imines (X = N) to quinolines presently proceeds in moderate yield, but remains surprising nonetheless. The polarities of the imine and ketene appear mismatched for electrocyclization, as the reaction joins two electrophilic carbon atoms. Current efforts aim to optimize these transformations so they occur in preparatively useful yields." SYNFORM, 2015/01
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Professor Ready concluded: "As we consider the ketenes and ynol ethers available through this coupling, we are now interested in investigating their reactivity in a variety of contexts. For example, ynols can participate in cycloaddition reactions, but have not been explored as completely as olefin reagents. Likewise, we continue to search for protocols to effect the direct addition of carbon-based nucleophiles to ketenes. Finally, the couplings described here fail when attempted on the corresponding bromides or hindered aryl iodides. We are eager to expand the scope of the reaction to accommodate these important substrate classes." Functionalized 1,2,3-triazoles have an important role in a large number of medicinally and materially useful compounds (Scheme 1, eq. 1). Furthermore, the substituted 1,2,3-triazole function is at the core of the most used bioconjugation technology based on the so-called 'click chemistry', so it is incorporated in a number of bioactive conjugates. Straightforward access to this important class of compounds has been feasible since the inception of versatile copper-catalyzed azidealkyne [3+2]-cycloaddition (CuAAC), ruthenium-catalyzed azide-alkyne [3+2]-cycloaddition (RuAAC) and iridium-catalyzed azide-alkyne [3+2]-cycloaddition (IrAAC) reactions, and thanks to the pioneering contributions of Meldel, Sharpless, Fokin and other research groups (Chem. Rev. 2013, 113, 4905) . In the meantime, other strategies such as Bertozzi's strain-promoted [3+2]-cycloaddition reactions and the Ramachary -Bressy-Wang enamine-mediated organocatalytic [3+2] cycloaddition of carbonyls (enones, β-keto esters, ketones and enals) with azides have also contributed significantly to the development of this area (Scheme 1, eq. 2) (for references, see the original paper).
Existing strategies often make use of either costly alkynes or less reactive carbonyl compounds, other than the simple aldehydes, as the starting materials along with aryl azides. Also, the alkynes used in CuAAC, RuAAC or IrAAC click reactions are costlier compared to the corresponding aldehydes. For example, the price of phenylacetylene is $76 for 100 mL whereas phenylacetaldehyde costs only $33 for the same amount. These limitations inspired Professor Dhevalapally Ramachary at the University of Hyderabad (India) to develop a novel green protocol for the high-yielding regioselective synthesis of 1,4-disubstituted 1,2,3-triazoles based upon enolate-mediated organocatalytic azide-aldehyde [3+2]-cycloaddition (OrgAAC) reaction from commercially available enolizable aldehydes, aryl azides and catalytic amounts of DBU (Scheme 1, eq. 3).
In continuation of their earlier studies of the organocatalytic synthesis of highly functionalized NH-1,2,3-triazoles dienamines, Professor Ramachary and co-workers described for the first time an efficient high-yielding enolate-mediated OrgAAC reaction of phenylacetaldehyde with phenyl azide at room temperaure for just 30 minutes under the DBU catalysis (Scheme 2). Professor Ramachary said: "An attractive feature of this OrgAAC reaction is that it provides an alternative method for accessing the library of 1,4-disubstituted 1,2,3-triazoles where metal-catalyzed or enamine-mediated click reactions either fail or are low-yielding (Scheme 3). This diversity-oriented approach displays a high degree of flexibility with different azides and the nature of base and solvent is crucial for obtaining the best results (Scheme 3)." After getting a clear understanding of the electronic factors of ArN 3 /RN 3 in the OrgAAC reaction, Professor Ramachary investigated the reaction scope with different 2-arylacetaldehydes in the OrgAAC reaction with PhN 3 (Scheme 4). "In this reaction, 2-arylacetaldehydes containing different functional groups, such as nitro, halo, alkyl, heteroaryl and methoxy, were used as substrates for the organocatalytic synthesis of the single isomer of 1,2,3-triazoles in good to excellent yields within 30 minutes," explained Professor Ramachary, continuing: "The results in Scheme 4 demonstrate the broad scope of this novel methodology, covering a structurally diverse groups of 2-arylacetaldehydes and phenyl azide. Many of the OrgAAC products were obtained in good yields compared to other routes."
In order to further understand the importance of the acidic nature of enolizable aldehydes in the OrgAAC reaction, Professor Ramachary's group chose simple aliphatic aldehydes, which have a less acidic α-methylene compared to 2-arylacetaldehydes (Scheme 5). Professor Ramachary said:
"Surprisingly, the reaction of simple aliphatic aldehydes with different aryl azides under the DBU or t-BuOK catalysis at 25°C for 30 minutes furnished the expected 1,2,3-triazoles in good yields." With industrial applications in mind, Professor Ramachary and co-workers investigated the gram-scale synthesis of 1,4-diphenyl-1H-1,2,3-triazole and 3-(4-phenyl-1H-1,2,3-triazol-1-yl)benzaldehyde from the DBU-promoted SYNFORM, 2015/01
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Scheme 3 Reaction scope with different azides reaction of 1.00 g of phenylacetaldehyde with 1.19 g of phenyl azide or 1.47 g of 3-azidobenzaldehyde in 17 mL of DMSO at 25 °C without compromising the reaction rate, yield or purity. Professor Ramachary remarked: "Recent developments in the metal-free synthesis of 1,2,3-triazoles are impressive, and the development of more sustainable variants is highly warranted since the click reaction has already found significant applications in pharmaceuticals and materials. However, the discovery of room-temperature reactions under the 'friendly' catalysts, namely simple molecules without extra ligands, environmentally friendly, cost-effective and that can be prepared in few synthetic steps, and employing reduced azide loading could be of immense interest in industrial applications. In this scenario, the aforementioned method provides rapid access to 1,4-di substituted 1,2,3-triazoles in both academic and industrial research." Professor Ramachary concluded: "This novel and more practical metal-free DBU-catalyzed [3+2]-cycloaddition reaction has a broad substrate scope, good functional-group tolerance, simple operation, and high reaction rate and efficiency, thus providing easy access to various 1,4-disubstituted 1,2,3triazoles. This reaction opens up new prospects in synthesis, materials and pharmaceutical chemistry for further exploiting the synthetic power of the amine-catalyzed enolate-mediated click reaction. 
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With more than 45 FDA approved drugs (Scheme 1, A) , nucleoside analogues constitute one of the most important classes of bioactive compounds. Nevertheless, most synthetic methods are based on linear multi-step sequences, making the synthesis of structurally diverse libraries of nucleoside analogues difficult. In particular, the carbohydrate ring of most nucleoside analogues is obtained from natural ribose or deoxy ribose, which limits the diversity of structures accessible. Recently, the group of Professor Jérôme Waser from the Labo ratory of Catalysis and Organic Synthesis, Ecole Polytechnique Fédérale de Lausanne (EPFL, Switzerland) reported a new method for synthesizing nucleoside analogues via a [3+2]-annulation reaction (Scheme 2). Professor Waser explained: "In our report, we presented a [3+2]-annulation method between carbonyls or silyl enol ethers and donoracceptor aminocyclopropanes for the convergent synthesis of nucleoside and carbonucleoside analogues in only a few steps. Derivatives of thymine, uracil and 5-fluorouracil could be obtained in good yield and broad structural diversity."
He continued: "The original inspiration for this project came a few years ago when we were working on cyclization reactions of aminocyclopropanes for the synthesis of natural alkaloids (Angew. Chem. Int. Ed. 2010, 49, 5767) . At that time, we became aware not only of the synthetic potential of aminocyclopropanes in synthesis, but also of the challenge associated with the synthesis of cyclization precursors including both a reactive aminocyclopropane and an internal nucleophilic site." Professor Waser reckoned that if an annulation reaction could be devised in which several bonds would be formed in a single process and the reacting nucleophile was in a different molecule, the synthesis of nitrogen-containing molecules, in particular nucleoside analogues, would be greatly facilitated (Scheme 1, B) . "The field of annulation reactions of donor -acceptor cyclopropanes is currently a very fertile field of research (Review: Angew. Chem. Int. Ed. 2014, 53, 5504) ," said Professor Waser, "nevertheless, aminocyclopropanes had not been used before in [3+2]-annulation reactions, probably because finding the right compromise between reactivity and stability is extremely challenging for this class of substrates." Professor Waser recalled that the first breakthrough came in 2011 when graduate student Florian de Nanteuil discovered the exceptional properties of phthalimide-substituted diester cyclopropanes at the start of his PhD research: "The combination of the two carbonyl groups to deactivate the nitrogen and the diester group allowing chelation to the metal was key to promoting a very efficient [3+2] annulation with enol ethers (Angew. Chem. Int. Ed. 2011, 50, 12075) (Scheme 2, C) ." Based on this result, Florian, together with Dr. Fides Benfatti, could then extend the reaction to carbonyls as partners (Org. Lett. 2012, 14, 744; Chem. Eur. J. 2012, 18, 4844) and develop an enantioselective method together with student Eloisa Serrano (J. Am. Chem. Soc. 2014, 136, 6239) .
"This important breakthrough brought us closer to an efficient synthesis of nucleoside analogues," said Professor Waser, who added: "In principle, deprotection of the phthalimide and elaboration of a nucleobase using known procedures could have been envisaged at this stage. However, this solution would require a long sequence of reactions and deprotection of phthalimide could not be achieved in the case SYNFORM, 2015/01
SYNSTORIES A12
Scheme 2 [3+2]-Annulation reaction for the synthesis of (carbo)nucleoside analogues of sensitive nucleoside derivatives. Clearly, a new approach was needed!" In particular, explained Professor Waser, if donor-acceptor cyclopropanes already bearing the nucleobase could be used, a convergent and efficient method would become available. He continued: "It was at this point (August 2012) that graduate student Sophie Racine joined our group under the support of the Swiss National Center of Competence in Research (NCCR) in chemical biology with the goal of generating a library of diverse nucleoside analogues for investigation of their bioactivity." Professor Waser recalled that based on the results obtained by Florian and Eloisa, Sophie started her research with the synthesis of thymine-substituted cyclopropanes. The choice of thymine was based on its structure, being close to phthalimide, with two carbonyl groups deactivating the nitrogen. "As so often in organic chemistry, a seemingly simple task on paper became a struggle in the laboratory: the highly polar nature of thymine and its tendency towards hydrogen bonding makes it insoluble in most organic solvents, and the two nitrogen atoms are a challenge for the regioselectivity of many reactions," said Professor Waser, who continued: "After several months of work, Sophie was finally able to synthesize thymine-substituted cyclopropanes bearing benzyl-or benzoyl-derived protecting groups. To our delight, our chemical intuition proved to be correct, and both cyclopropanes could be used in the [3+2] annulation with aldehydes. However, we then realized that neither protecting group could be removed without complete decomposition of the nucleoside analogues. We needed to use another more labile protecting group and decided to focus on the tert-butoxycarbonyl (Boc) group."
Again, accessing the required donor -acceptor cyclopropanes was not an easy task. The more labile Boc group could not be used in the synthetic sequence developed previously. "Fortunately, Sophie was able to develop a new regioselective vinylation of thymine, which set the basis for a three-step synthesis of the desired donor-acceptor cyclopropane," said Professor Waser, who explained that with this key substrate in hand, optimizing the [3+2] annulation was more straightforward. Nevertheless, important variations in isolated yield were still observed from batch to batch. "Sophie realized that this was due to partial removal of the Boc protecting group during reaction or column chromatography," said Professor Waser. "To obtain reproducible results, the easiest solution was to completely deprotect the crude product by heating in ethanol at reflux. After more than a year of struggle, Sophie was finally able to obtain the desired nucleoside and carbonucleoside analogues using 20 mol% of In(OTf) 3 with aldehydes or 10 mol% of SnCl 4 with ketones and enol ethers in 51-97% yield!" Sophie Racine was also able to extend the method to uracil and 5-fluorouracil derivatives and to modify the obtained diesters into alcohols more frequently encountered in bioactive compounds. In the case of 5-fluorouracil, the Boc protecting group was too labile. Fortunately, added Professor Waser, the more stable benzoyl group could be removed under mild conditions in this case.
"In conclusion, we were able for the first time to use donor -acceptor cyclopropanes for the synthesis of (carbo)nucleoside analogues," said Professor Waser. The correct modulation of the electronic properties of the substituent on the nitrogen atom was essential to reach the right balance between reactivity and stability. "The pioneering work described in our communication paved the way to answering many other fascinating questions in synthetic and medicinal chemistry," said Professor Waser. "Can this strategy be extended to all the nucleobases and their non-natural analogues? Can we develop an enantioselective access to the building blocks? Can we increase the structural diversity of both partners in the annulation step? Will the screening for bioactivity (currently ongoing at EPFL) result in the discovery of new biological modes of actions? As we see, there are still many challenges awaiting Sophie until the end of her PhD!" he concluded.
